Article
Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease.
Oncology - 1 Jan 2017
Ogata Fumihiro, Kobayashi Masahiro, Akuta Norio, Osawa Mitutaka, Fujiyama Shunichiro, Kawamura Yusuke, Sezaki Hitomi, Hosaka Tetsuya, Kobayashi Mariko, Saitoh Satoshi, Suzuki Yoshiyuki, Suzuki Fumitaka, Arase Yasuji, Ikeda Kenji, Kumada Hiromitsu
Abstract excerpt
OBJECTIVES: There is little information on the risk factors for hepatocellular carcinoma (HCC) and outcome of treatment with an all-oral combination of direct-acting antiviral regimens following eradication of hepatitis C virus (HCV) RNA. METHODS: The study subjects were 1,170 patients with HCV genotype 1-related chronic liver disease treated with either NS5A inhibitor plus NS3/4A protease inhibitor (n = 707),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.